Literature DB >> 16998600

Post-menopausal bleeding: a rare presentation of metastatic uveal melanoma.

Michael A Coutts1, Nicola J Borthwick, John L Hungerford, Ian A Cree.   

Abstract

Uveal melanoma differs from cutaneous melanoma in many ways, including its pattern of metastasis, and exhibits latency with clinical evidence of metastasis sometimes appearing many years after primary diagnosis. Most patients develop metastasis within the liver, but some may present with metastasis to other sites. We report a case of uveal melanoma that presented with post-menopausal bleeding due to metastasis. Further investigation revealed widespread metastatic disease and the patient was not fit for chemotherapy. She died two months after presentation: autopsy revealed metastases in many sites, including the uterus, right ovarian fibroma, kidney, mesentery, liver, lung, thyroid, bone marrow and skin. The immediate cause of death was cardiac tamponade due to a malignant effusion secondary to cardiac metastasis. This case illustrates the widespread metastatic potential of uveal melanoma and highlights the potential for unusual presentation of metastatic disease from this eye tumor.

Entities:  

Mesh:

Year:  2006        PMID: 16998600     DOI: 10.1007/bf02893367

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  21 in total

1.  MALIGNANT MELANOMAS OF THE UVEA IN DENMARK 1943-1952. A CLINICAL, HISTOPATHOLOGICAL, AND PROGNOSTIC STUDY.

Authors:  O A JENSEN
Journal:  Acta Ophthalmol (Copenh)       Date:  1963

2.  Diagnosis of a solitary cardiac metastasis from ocular melanoma.

Authors:  Gabriel T Chong; Raymond J Kim; Srivani R Ambati; Terence Z Wong; Louis R Dibernardo; Elmar M Merkle; Thomas Ryan; Michael A Morse
Journal:  J Thorac Cardiovasc Surg       Date:  2005-12       Impact factor: 5.209

3.  Malignent melanomas of the human uvea. Recent follow-up of cases in Denmark, 1943-1952.

Authors:  O A Jensen
Journal:  Acta Ophthalmol (Copenh)       Date:  1970

4.  Recruiting donors for autopsy based cancer research.

Authors:  J Thombs; N J Borthwick; J L Hungerford; I A Cree
Journal:  J Med Ethics       Date:  2005-06       Impact factor: 2.903

5.  Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years.

Authors:  J A Shields; J J Augsburger; L A Donoso; V B Bernardino; M Portenar
Journal:  Am J Ophthalmol       Date:  1985-11-15       Impact factor: 5.258

6.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

7.  Uveal melanoma in association with multiple malignancies. A case report and review.

Authors:  K R Rednam; L M Jampol; R A Levine; M F Goldberg
Journal:  Retina       Date:  1981       Impact factor: 4.256

8.  Reappraisal of Callender's spindle a type of malignant melanoma of choroid and ciliary body.

Authors:  I W McLean; L E Zimmerman; R M Evans
Journal:  Am J Ophthalmol       Date:  1978-10       Impact factor: 5.258

9.  Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases.

Authors:  N B Kumar; W R Hart
Journal:  Cancer       Date:  1982-11-15       Impact factor: 6.860

10.  Abnormal uterine bleeding as a presenting sign of metastasis to the endometrium in a patient with a history of cutaneous malignant melanoma.

Authors:  Bulent Berker; Ayse Sertcelik; Gulsah Kaygusuz; Cihat Unlu; Firat Ortac
Journal:  Gynecol Oncol       Date:  2004-04       Impact factor: 5.482

View more
  2 in total

Review 1.  Endometrial metastasis of primary malignant melanoma of the brain.

Authors:  Jessica Little; Kathleen Braniff
Journal:  BMJ Case Rep       Date:  2018-05-30

2.  Multinodular goiter and primary hyperparathyroidism: a circuitous route to diagnosing metastatic uveal melanoma.

Authors:  Constantine G A Theoharis; Tobias Carling; Natalia Buza; Eduardo Zambrano; Julie Ann Sosa
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.